Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

No-Radiation breast scanner could change cancer detection

NCT ID NCT05300464

Diagnosis Sponsor: Umbria Bioengineering Technologies Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called MammoWave that uses low-power microwaves instead of X-rays to find breast lesions. About 600 women will lie face-down while the device scans their breasts for about 10 minutes. The goal is to see if this safe, radiation-free method can accurately detect breast abnormalities compared to standard mammography.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MammoWave microwave mammogram device
What this could lead to
If successful, this could offer a safe, radiation-free alternative to traditional mammograms for breast cancer detection.
What could go wrong
This is an early-stage device study. It may not be as accurate as standard mammography, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed Informed consent Form * Women * Adult ≥ 18 years old * Having a radiologist study output obtained using mammography within the last month. Such radiologist study output may be integrated with ultrasound and /or magnetic resonance imaging output if deemed necessary by the responsible investigator and when available. The radiological output will be integrated with histological one if deemed necessary by the responsible investigator and when available. * Patients willing to comply with study protocol and recommendations Exclusion Criteria: * Patients who belong to any vulnerable group * Patients with implanted electronic devices * Patients who have undergone biopsy less than one week before MammoWave scan * Patients with nipple piercings (unless they are removed prior to examination) * Pregnancy or breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign breast lesion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast benign neoplasm breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Az. San. Univ. Giuliano Isontina (ASU GI)

    RECRUITING

    Trieste, 34128, Italy

  • Hospital Universitario de Toledo

    RECRUITING

    Toledo, Spain, 45007, Spain

  • IRCCS Policlinico San Martino

    RECRUITING

    Genova, Genova, 16132, Italy

  • Ospedale San Giovanni Battista - USL Umbria 2

    RECRUITING

    Foligno, Perugia, 06034, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.